PMC:7309518 / 4942-5029 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T84","span":{"begin":51,"end":53},"obj":"Disease"}],"attributes":[{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0017941"}],"text":"), hyposmia (5.1%), and very high creatine kinase (CK) levels, with myalgia (in 19.3%) "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":34,"end":42},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A17","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"}],"text":"), hyposmia (5.1%), and very high creatine kinase (CK) levels, with myalgia (in 19.3%) "}

{"project":"LitCovid-PubTator","denotations":[{"id":"170","span":{"begin":34,"end":49},"obj":"Gene"},{"id":"171","span":{"begin":51,"end":53},"obj":"Gene"},{"id":"186","span":{"begin":3,"end":11},"obj":"Disease"},{"id":"187","span":{"begin":68,"end":75},"obj":"Disease"}],"attributes":[{"id":"A170","pred":"tao:has_database_id","subj":"170","obj":"Gene:51727"},{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"Gene:51727"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"MESH:D000857"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"MESH:D063806"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"), hyposmia (5.1%), and very high creatine kinase (CK) levels, with myalgia (in 19.3%) "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T31","span":{"begin":3,"end":11},"obj":"Phenotype"},{"id":"T32","span":{"begin":68,"end":75},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0004409"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0003326"}],"text":"), hyposmia (5.1%), and very high creatine kinase (CK) levels, with myalgia (in 19.3%) "}